Page 131 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GESMD
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
• Clinical Implications of P53 Dysfunction in Patients with Myelodysplastic Syndromes. 64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Or- leans (USA), 10-13 de diciembre de 2022.
Riva E, Zampini M, Termanini A, Dall’olio L, Merlotti A, Kulasekararaj A, Calvi M, Di Vito C, Rahal D, Bonometti A, Croci G, Boveri E, Gianelli U, Ponzoni M, Russo A, Tinterri B, Re F, Sauta E, Saba E, Travaglino E, Ubezio M, Campagna A, Lanino L, Maggioni G, Tentori CA, Milanesi C, Manes N, D’amico S, Ficara F, Crisafulli L, Mavilio D, Lugli E, Santoro A, Díez- Campelo M, Sanz G, Solé F, Platzbecker U, Santini V, Kordasti S, Fenaux P, Haferlach T, Remondini D, Castellani G, Della Porta MG, On Behalf Of Genomed4all Consortium (Ge- nomics and Personalized Medicine For all Through Artificial Intelligence in Haematologi- cal Diseases-www .Genomed4all .eu) .
• WT1 mRNA Upregulation in Acute Myeloid Leukemia (AML) in Complete Molecular Remission (MCR): Understanding the Limitations and Potential Advantages of WT1 as a Measurable Residual Disease (MRD) Target.
64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Or- leans (USA), 10-13 de diciembre de 2022.
Esquirol A, Guillén Y, Bussaglia E, Criado V, Carricondo M, Acha P, Esteller M, Sierra J, Solé F, Bigas A, Nomdedéu JF .
• Tp53 Allelic State in Myelodysplastic Syndromes with 5q Deletion.
64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Orle- ans (USA), 10-13 de diciembre de 2022.
Montoro MJ, Palomo L, Vidal P, Solé F, Such E, Fuster-Tormo F, González T, Ortega M, López F, García-Ávila S, García-Gisbert N, Rivero E, Díez-Campelo M, Jerez A, Bosch F, Valcárcel D .
• Inter-Laboratory Comparison Study of Optical Genome Mapping Analysis for Cytoge- nomic Characterization of Hematological Malignancies: a Spanish Multi-Center Study. 64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Or- leans (USA), 10-13 de diciembre de 2022.
Puiggrós A, Mallo M, Salido M, Gómez-García A, García-Serra R, Cisneros A, González C, Avestisyán G, Rodríguez-Rivera M, Díaz A, Granada I, Such E, Genescà E, Collado R, Ramírez-Orellana M, Solé F, Espinet B .
• Long-Term Evolution of Somatic Mutations in Patients with Del(5q) MDS Early Treat- ed with Lenalidomide in the SINTRA-REV Clinical Trial: Safe and Effective Approach? 64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Orleans (USA), 10-13 de diciembre de 2022.
Toribio Castelló SM, López-Cadenas F, Preudhomme C, Villaverde Ramiro A, Fenwarth 131